148 related articles for article (PubMed ID: 36277724)
1. Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil.
Silveira VB; Schwengber WK; Hetzel GM; Zanella AB; Scheffel RS; Maia AL; Dora JM
Front Endocrinol (Lausanne); 2022; 13():995329. PubMed ID: 36277724
[TBL] [Abstract][Full Text] [Related]
2. Patterns of radioiodine use for differentiated thyroid carcinoma in Brazil: insights and a call for action from a 20-year database.
Schwengber WK; Mota LM; Nava CF; Rodrigues JAP; Zanella AB; De Souza Kuchenbecker R; Scheffel RS; Maia AL; Dora JM
Arch Endocrinol Metab; 2021 Nov; 64(6):824-832. PubMed ID: 33085995
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cancer burden and economic impact on the Brazilian public health system.
Janovsky CCPS; Bittencourt MS; Novais MAP; Maciel RMB; Biscolla RPM; Zucchi P
Arch Endocrinol Metab; 2018 Oct; 62(5):537-544. PubMed ID: 30462807
[TBL] [Abstract][Full Text] [Related]
4. The effect of COVID-19 pandemic restrictions on the management of differentiated thyroid cancer in Turkey: a single tertiary centre experience.
Calapkulu M; Sencar ME; Ozturk Unsal I; Sakiz D; Tekinyildiz M; Ozbek M; Cakal E
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2587-2595. PubMed ID: 38347198
[TBL] [Abstract][Full Text] [Related]
5. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life of thyroid cancer patients undergoing radioiodine therapy: a cohort real-world study in a reference public cancer hospital in Brazil.
Ramim JE; Cardoso MAS; de Oliveira GLC; Gomes ML; Guimarães TT; de Mello RCR; Bergmann A; Pujatti PB
Support Care Cancer; 2020 Aug; 28(8):3771-3779. PubMed ID: 31832820
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
[TBL] [Abstract][Full Text] [Related]
9. Core needle biopsy of thyroid nodules - evaluation of diagnostic utility and pain experience.
Stangierski A; Wolinski K; Martin K; Leitgeber O; Ruchala M
Neuro Endocrinol Lett; 2013; 34(8):798-801. PubMed ID: 24522016
[TBL] [Abstract][Full Text] [Related]
10. Nondiagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants.
Jack GA; Sternberg SB; Aronson MD; Mukamal KJ; Oshin A; Hennessey JV
Thyroid; 2020 Jul; 30(7):992-998. PubMed ID: 31950884
[No Abstract] [Full Text] [Related]
11. Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients.
Drozd V; Schneider R; Platonova T; Panasiuk G; Leonova T; Oculevich N; Shimanskaja I; Vershenya I; Dedovich T; Mitjukova T; Grelle I; Biko J; Reiners C
Front Endocrinol (Lausanne); 2020; 11():567385. PubMed ID: 33193085
[No Abstract] [Full Text] [Related]
12. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
13. Profile of thyroidectomies in Brazil from 2010 to 2020 from a macro-regional perspective.
Braga JP; de Barros Bentes LG; Lemos RS; Almeida NRC; Fernandes MRN; Andrade GL; de Araújo VMM; Dos Santos DR
Arch Endocrinol Metab; 2023 Mar; 67(3):372-377. PubMed ID: 37011372
[TBL] [Abstract][Full Text] [Related]
14. The impact of the COVID-19 pandemic on thyroid nodular disease: a retrospective study in a single center in the western part of Romania.
Popa O; Barna RA; Borlea A; Cornianu M; Dema A; Stoian D
Front Endocrinol (Lausanne); 2023; 14():1221795. PubMed ID: 37497351
[TBL] [Abstract][Full Text] [Related]
15. Histologic outcome of thyroid nodules with repeated diagnosis of atypia in thyroid fine-needle aspiration biopsy.
Selek A; Cetinarslan B; Kıvrakoğlu E; Karadağ DT; Tarkun I; Canturk Z; Akyay OZ
Future Oncol; 2016 Mar; 12(6):801-5. PubMed ID: 26838590
[TBL] [Abstract][Full Text] [Related]
16. Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.
Tala H; Robbins R; Fagin JA; Larson SM; Tuttle RM
J Clin Endocrinol Metab; 2011 Jul; 96(7):2105-11. PubMed ID: 21565788
[TBL] [Abstract][Full Text] [Related]
17. Utility of thyroglobulin measurements in fine-needle aspirates of space occupying lesions in the thyroid bed after thyroid cancer operations.
Suh YJ; Son EJ; Moon HJ; Kim EK; Han KH; Kwak JY
Thyroid; 2013 Mar; 23(3):280-8. PubMed ID: 22950788
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided fine-needle aspiration biopsy of the thyroid.
Tambouret R; Szyfelbein WM; Pitman MB
Cancer; 1999 Oct; 87(5):299-305. PubMed ID: 10536356
[TBL] [Abstract][Full Text] [Related]
19. Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
Dunn LA; Sherman EJ; Baxi SS; Tchekmedyian V; Grewal RK; Larson SM; Pentlow KS; Haque S; Tuttle RM; Sabra MM; Fish S; Boucai L; Walters J; Ghossein RA; Seshan VE; Ni A; Li D; Knauf JA; Pfister DG; Fagin JA; Ho AL
J Clin Endocrinol Metab; 2019 May; 104(5):1417-1428. PubMed ID: 30256977
[TBL] [Abstract][Full Text] [Related]
20. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
